Hong Kong Baptist University

Changshu Hkbu Technology Company Limited

Albert Sun Chi Chan

Zhaoxiang Bian

Aiping Lu

Chengyuan Lin

Dajian Yang

Shilin Chen

Hongxi Xu

Huaixue Mu

Kaixian Chen

Hong Jie Zhang

Yuanzhi Lao

Xiaoyu Wang

Siu Wai Tsang

Hong Wei Zhang

Xin Li

Baomin Fan

Yongyun Zhou

Zhijun Yang

Zhao-xiang Bian

Cheng-yuan Lin

Shi-lin Chen

Da-jian Yang

Jinjin Wang

Ai-ping Lu

Hong-xi Xu

Hongsheng Tan

Yuan-zhi Lao

Zhi-jie Ding

Weimin Zeng

Kai-xian Chen

Siu Po Ip

Hong-sheng Tan

Che Yuen Justin Wu

The present invention relates to chemical constituents of the hydro-alcoholic extract of root of(L.) Thwait. More particularly, it relates to the bioactive chemical composition of(L.) Thwait and its anticancer effect. The present invention has application in the treatment of human esophageal carcinoma.

[object Object]

The present invention relates to the bioactive components with the anti-proliferative property. In particular, the invention relates to one flavonol compound isolated from the root ofLinn. Thwait or chemically synthesized and its specific anticancer/antitumor activity. This invention has a specific application in treating human esophageal cancer.

Anti-esophageal cancer compound and method of use thereof

The present invention provides compound extracted fromspecies and the use of said compound in preventing and treating cancer.

Prostate cancer is the most commonly diagnosed cancer in males and one of the leading causes of cancer death. Although treatment options have increased for some patients, overall progress has been modest. Thus, there is a great need to develop new treatments. This invention relates to a method for treating cancer comprising using an anti-cancer compound of formula (I):  More particularly, it relates to said anti-prostate cancer compound that can be isolated fromor chemically synthesized and its specific anticancer/antitumor activity. The invention has a specific application in treating human prostate cancer.

Pharmaceutical composition comprising guttiferone F for the treatment of prostate cancer

Cervical cancer is one of the most common malignancies and is associated with a dismal prognosis. The most common therapeutic option for cervical cancer consists of surgery in early stages, and chemotherapy or radiotherapy in more advanced stages of the disease. Although treatment options have increased for some patients, overall progress has been modest. This invention relates to a method for treating cancer comprising administering an anti-cancer compound. More particularly, the present invention relates to an anti-cervical-cancer compound for treating human cervical cancer and tumor.

Anti-cervical cancer compound and method of use thereof

The present invention relates to chemical entities originated from natural sources and further synthesized for therapeutic uses. More particularly, the present invention relates to norcantharidin analogs synthesized by a transition metal-catalyzed alkynylation of oxanorbornadiene derivatives and their antitumor effects.

Oxanorbornadiene derivatives and their anticancer activities

This invention relates to a Chinese medicinal formulation for the treatment of inflammatory bowel diseases, and a method of preparation thereof. The formulation comprises herbal components selected from a group consisting of Radix Codonopsis (Dangshen), Rhizoma Atractylodis Macrocephalae (Bai Zhu), Sclerotium Poriae Cocos (Fu Ling), Rhizoma Zingiberis Officinalis (Gan Jiang), Radix Paeoniae Alba (Bai Shao) and Rhizoma Coptidis (Huanglian).

Chinese medicinal formulation for treating inflammatory bowel disease and the preparation thereof

Growing community of inventors

Hong Kong, China

Albert Sun Chi Chan